New Approach Methodologies in Drug Discovery from a Safety and Efficacy Perspective
Colloquium

 New Approach Methodologies (NAMs) in Drug Discovery from a Safety and Efficacy

Perspective Colloquium

​

We warmly invite you to our "New Approach Methodologies (NAMs) in Drug Discovery from a Safety and Efficacy Perspective" Colloquium Event. Experts will be discussing on preclinical stages of potential therapeutic molecules, key challenges in early stages of drug development and how to overcome these challenges with NAMs, the balance between safety and efficacy in translation to clinical phases, and finally the role of regulatory authorities in this translation process. The event will take place in İzmir on 20th of November, 2026. Attendence is limited, we advise you to secure your seats quickly!

 

Event Flow

​

• Licensing process of therapeutic candidates and the role of regulatory authorities.

• Unified evaluation of different datasets in IND applications.

• Technical, biological, and regulational challenges in early stages of drug development.

• Traditional in vitro models and their capacity of assessing safety and efficacy.

• Safety and efficacy assessment with the integration of in silico approaches.

• Employing NAMs to increase clinical efficacy. 

• A roadmap for Türkiye to adapt to this transformation.

 

​20 November 2026

 

          Izmir

​

          Registration will be available from September 1, 2026

​

​